1 February 2023 in Orthodontics & Craniofacial Research
Objectives: Skeletal malocclusions are common, and severe malocclusions are treated by invasive surgeries. Recently, jaw bone length has been shown to be developmentally controlled by osteoclasts. Our objective was to determine the effect of inhibiting osteoclast‐secreted proteolytic enzymes on lower jaw bone length of avian embryos by pharmacologically inhibiting matrix metalloproteinase‐9 (MMP9) or cathepsin K (CTSK).Methods: Quail (Coturnix coturnix japonica) embryos were given a single dose of an inhibitor of MMP9 (iMMP9), an inhibitor CTSK (iCTSK), or vehicle at a developmental stage when bone deposition is beginning to occur. At a developmental stage when the viscerocranium is largely calcified, the heads were scanned via micro‐computed tomography and reproducible landmarks were placed on 3D‐reconstructed skulls; the landmark coordinates were used to quantify facial bone dimensions.Results: Approximately half of the quail given either iMMP9 or iCTSK demonstrated an overt lower jaw phenotype, characterized by longer lower jaw bones and a greater lower to upper jaw ratio than control embryos. Additionally, iMMP9‐treated embryos exhibited a significant change in midface length and iCTSK‐treated embryos had significant change in nasal bone length.Conclusion: MMP9 and CTSK play a role in osteoclast‐mediated determination of lower jaw bone length. Pharmacological inhibition of MMP9 or CTSK may be a promising therapeutic alternative to surgery for treating skeletal jaw malocclusions, but more preclinical research is needed prior to clinical translation.
7 April 2026 in JBMR Plus
Robinow syndrome has characteristic craniofacial and dental features and can be caused by gain- or loss-of-function variants in Wnt family member 5A (WNT5A) non-canonical signaling. The craniofacial and dental manifestation of Robinow syndrome is heterogenous, as is the effect of altered Wnt5a in animal models. The relationship between Wnt5a and craniofacial and dental phenotypes is not fully understood. To investigate the role of Wnt5a in bone during craniofacial and dental development, we utilized a Wnt5a conditional loss-of-function (LOF: Wnt5afl/fl;Ctskcre) and a Wnt5a conditional gain-of-function (GOF: Rosa26-LSL-Wnt5a;Ctskcre) model to determine the effect of both LOF and GOF of Wnt5a in bone cells during craniofacial and dental development. Postnatal day 10 conditional LOF Wnt5a, GOF Wnt5a, and control skulls were scanned by micro-computed tomography and assessed using traditional and geometric morphometrics. Mandibular bone apoptosis was further assessed by TUNEL staining. Conditional Wnt5a LOF resulted in midface hypoplasia, increased maxillary intermolar width, increased rostral basisphenoid width, and delayed molar eruption. Wnt5a LOF mandibles did not have altered bone mineral density or bone microarchitecture unlike our previous study examining Wnt5a LOF femurs. In contrast, conditional Wnt5a GOF results in macrocephaly, shortened hard palate, increased zygomatic length, micrognathia, and mandibular process dysmorphology. The micrognathia and mandibular process dysmorphology in the Wnt5a GOF mice were not due to increased apoptosis. A partially penetrant snout deviation was present in both the Wnt5a LOF and GOF mice. Craniofacial and dental phenotype differed between mice with conditional GOF and LOF of Wnt5a, consistent with the craniofacial phenotype heterogeneity in WNT5A-associated Robinow syndrome. We detected tooth eruption delay, mandibular condyle dysmorphology, and facial asymmetry in mice with altered Wnt5a that have not been previously reported in patients with WNT5A-associated Robinow syndrome. Our data suggest precise regulation of Wnt5a is essential for proper craniofacial and dental development. Robinow syndrome is a rare disease that affects skull and facial bones. It is linked to changes in a gene called Wnt5a. To better understand how disruption of Wnt5a affects bone, researchers studied mice with either increased or decreased Wnt5a in bone cells. These mice showed a range of facial and dental anomalies, including changes in jaw and skull shape and tooth eruption timing. Some changes resembled those seen in people with Robinow syndrome, while others were new findings. This research shows that careful control of Wnt5a is crucial for the development of the face.